Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Spinal Cord Compression 1 Sleep Apnea, Obstructive 1 Sleep Apnea Syndromes 1 Recurrence 1 Postoperative Complications 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 COVID-19 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Temozolomide 163 Radiosurgery 129 Radiotherapy 107 Bevacizumab 98 Magnetic Resonance Spectroscopy 75 Carboplatin 48 Surgical Procedures, Operative 35 pembrolizumab 34 Radiation 34 Etoposide 34 Nivolumab 33 Irinotecan 33 Cyclophosphamide 33 Erlotinib Hydrochloride 31 Carmustine 28 Lomustine 26 Trastuzumab 25 Cisplatin 25 Ipilimumab 24 Filgrastim 23 Mental Status and Dementia Tests 21 Magnetic Resonance Imaging 21 Aminolevulinic Acid 21 Vincristine 20 Surveys and Questionnaires 19 Capecitabine 19 Topotecan 18 Specimen Handling 18 Pemetrexed 18 Radiotherapy, Intensity-Modulated 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Glucocorticoids × Clear all

NCT04042220 2024-01-05

Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases

Medical University of Vienna

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡